drugset
drugset / Trial / NCT07422298

A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants

NCT07422298 ↗

Phase 1 Recruiting 32 enrolled Bristol-Myers Squibb
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of BMS-986278 on the cardiac repolarization in healthy participants.

Timeline

Start
2026-02-19
Primary completion
2026-06-15
Completion
2026-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Admilparant Small molecule — —
Subject Moxifloxacin Small molecule — —

Indications

No indication recorded.